High-dose isoniazid therapy for isoniazid-resistant murine Mycobacterium tuberculosis infection

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 12, 1999, Pages 2922-2924

  Cynamon, M H ^a   Zhang, Y ^b   Harpster, T ^a   Cheng, S ^b   DeStefano, M S ^a  

^a SYRACUSE VA MEDICAL CENTER   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CARBON DIOXIDE; ISONIAZID; PYRIDOXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIUM MUTANT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 0032805940     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.12.2922     Document Type: Article

References (17)

1. Banerjee, A., E. Dubnau, A. Quemard, V. Balasubramanian, K. S. Um, T. Wilson, D. Collins, G. de Lisle, and W. R. Jacobs, Jr. 1994. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263:227-230.
2. Biehl, J. P., and H. J. Nimitz. 1954. Studies on the use of a high dose of isoniazid. Am. Rev. Tuberc. 70:430-441.
3. Kapur, V., L. L. Li, M. R. Hamrick, B. B. Plikaytis, T. M. Shinnick, A. Telenti, W. R. Jacobs, Jr., A. Banerjee, S. Cole, K. Y. Yuen, et al. 1995. Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch. Pathol. Lab. Med. 119:131-138.
4. Kirk, R. E. 1986. Experimental design: procedures for the behavioral sciences. Brooks-Cole Publishing Co., Belmont, Calif.
5. Klemens, S. P., M. S. DeStefano, and M. H. Cynamon. 1993. Therapy of multidrug-resistant tuberculosis: lessons from studies with mice. Antimicrob. Agents Chemother. 37:2344-2347.
6. Klemens, S. P., C. A. Sharpe, and M. H. Cynamon. 1994. Activity of levofloxacin in a murine model of tuberculosis. Antimicrob. Agents Chemother. 38:1476-1479.
7. Klemens, S. P., and M. H. Cynamon. 1996. Activity of KRM-1648 in combination with isoniazid against Mycobacterium tuberculosis in a murine model. Antimicrob. Agents Chemother. 40:298-301.
8. Klemens, S. P., and M. H. Cynamon. Unpublished data.
9. Mdluli, K., R. A. Slayden, Y. Zhu, S. Ramaswamy, X. Pan, D. Mead, D. D. Crane, J. M. Musser, and C. E. Barry III. 1998. Inhibition of a Mycobacterium tuberculosis β-ketoacyl ACP synthase by isoniazid. Science 280:1607-1610.
10. Mitchison, D. A., and A. J. Nunn. 1986. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am. Rev. Respir. Dis. 133:423-430.
11. Moulding, T. S. 1981. Should isoniazid be used in retreatment of tuberculosis despite acquired isoniazid resistance? Am. Rev. Respir. Dis. 123:262-264.
12. Musser, J. M., V. Kapur, D. L. Williams, B. N. Kreiswirth, D. van Soolingen, and J. D. Van Emden. 1996. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J. Infect. Dis. 173:196-202.
13. Victor, T. C., R. Warren, J. L. Butt, A. M. Jordaan, J. V. Felix, A. Venter, F. A. Sirgel, H. S. Shaaf, P. R. Donald, M. Richardson, M. H. Cynamon, and P. D. Van Helden. 1997. Genome and MIC stability in Mycobacterium tuberculosis and indications for continuation of use of isoniazid in multidrugresistant tuberculosis. J. Med. Microbiol. 46:847-857.
14. Weber, W. W., and D. W. Hein. 1979. Clinical pharmacokinetics of isoniazid. Clin. Pharmacokinet. 4:401-422.
15. Wong, C. S., G. S. Palmer, and M. H. Cynamon. 1988. In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium kansasii to amoxycillin and ticarcillin in combination with clavulanic acid. J. Antimicrob. Chemother. 22:863-866.
16. World Health Organization. 1997. Antituberculosis drug resistance in the world: the WHO/IUALTD Global Project on Antituberculosis Drug Resistance Surveillance. World Health Organization, Geneva, Switzerland.
17. Zhang, Y., B. Heym, B. Allen, D. Young, and S. Cole. 1992. The catalaseperoxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358:591-595.